TATAA Biocenter
TATAA Biocenter to Distribute SensID MDx Reference Standards
SensID specializes in the development, manufacture, and marketing or reference materials and quality controls for DNA-based diagnostics.
In Brief This Week: Exosome Dx, Theradiag, CAP, Qiagen, and More
Exosome Diagnostics said this week that it has expanded the coverage of its ExoDx Prostate IntelliScore (EPI) cancer test to an additional 82 million covered lives in the US, bringing the total to about 100 million.